ada standards of care 2025 glp-1 dpp-4 combination not recommended 🔴 Holistic Treatment Diabetes: of ▪️ Cardiovascular risk: Use RA or SGLT2 inhibitors for glycemic control & cardiovascular risk reduction. ▪️ Heart failure: SGLT2 inhibitors Dipeptidyl Peptidase 4 Inhibitors: Novel

Serious side effects (pancreatitis, severe gallbladder disease, acute kidney injury, severe hypoglycemia) can cause organ damage or life-threatening emergencies and require immediate medical intervention

& Bagetta, G

Manufacturer Comparison: Formulation, Mechanism, and Clinical Evidence Each manufacturer's GLP-1 product differs in receptor selectivity, pharmacokinetics, and demonstrated efficacy

For example, optimal levels of both diet and exercise increases bone mineralization during childhood, a critical period of growth and development, and this lessens their risk of osteoporosis and bone fractures later in life